Thermo Fisher reports third-quarter results on Wednesday

Thermo Fisher Scientific will release its third-quarter financial results on Wednesday, October 21, 2026, before the market opens. The company confirmed the schedule in an investor announcement.

The consensus estimate calls for earnings of 6.47 USD per share on revenue of 12.06 billion USD for the third quarter. Over the last four quarters, the company beat consensus earnings estimates each time by margins ranging between 0.9% and 4.5%.

Other published forecasts offer additional benchmarks. A consensus compiled by Zacks expects third-quarter adjusted earnings per share of 6.40 USD. A consensus compiled by Hudson Labs projects third-quarter GAAP earnings per share of 5.03 USD and revenue of 11,949 million USD. For the third quarter, Thermo Fisher set an organic revenue growth guidance target of 4%. For the full year 2026, a consensus compiled by Barchart anticipates adjusted earnings per share of 25.13 USD.

Since its previous earnings report, Thermo Fisher announced several business developments. On September 15, 2026, the company and Mayo Clinic launched Precure, LLC to identify early biological signs of disease. On September 23, 2026, it released the Gibco CHO-K1 Catalog Panel of basal and feed media for biologics developers. On September 28, 2026, Thermo Fisher signed a reseller agreement with Evosep to distribute the Evosep Eno separation platform globally alongside its mass spectrometry systems. On October 5, 2026, the company reported that its proteomics platforms helped detect 2,762 genetic-protein links in Singapore's PRECISE-SG100K study.